Skip to main content
David Frank, MD, Oncology, Atlanta, GA

DavidAlanFrankMD

Oncology Atlanta, GA

Hematologic Oncology

Director of the Division of Hematology, Professor of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute

Dr. Frank is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Frank's full profile

Already have an account?

Education & Training

  • Brigham and Womens Hospital
    Brigham and Womens HospitalFellowship, Hematology and Medical Oncology, 1990 - 1993
  • Yale-New Haven Hospital
    Yale-New Haven HospitalResidency, Internal Medicine, 1986 - 1989
  • Yale School of Medicine
    Yale School of MedicineClass of 1986

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2021 - 2022
  • MA State Medical License
    MA State Medical License 1990 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians, 2002

Publications & Presentations

PubMed

Journal Articles

  • Study of Cathepsin B Inhibition in VEGFR TKI Treated Human Renal Cell Carcinoma Xenografts  
    David A Frank, Rupal S Bhatt, Seth L Alper, Prateek Khanna, Nature

Abstracts/Posters

  • Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative Studies
    David A. Frank, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Cancer Care Patients and Families Prioritize High-Quality Relationships and Communication
    Cancer Care Patients and Families Prioritize High-Quality Relationships and CommunicationSeptember 21st, 2017
  • Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and NeckNovember 9th, 2016
  • Covid-19 AI Update: NIH Developing Imaging Tools
    Covid-19 AI Update: NIH Developing Imaging ToolsAugust 14th, 2020

Grant Support

  • Dual Stat3/Nf-Kb Inhibitors For Targeted Cancer TherapyNational Cancer Institute2012
  • STAT3 In The Pathogenesis And Treatment Of Pancreatic CancerNational Cancer Institute2006–2007
  • High Throughput Screening For Modulators Of STAT5 (RMI)National Institute Of Neurological Disorders And Stroke2004
  • STAT Signaling In Chronic Lymphocytic LeukemiaNational Cancer Institute1999–2003

Professional Memberships